Cargando…

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence

We retrospectively evaluated the clinical outcomes of patients with oligometastatic lung tumors who underwent stereotactic body radiotherapy (SBRT). Twenty-two patients with one or two oligometastatic lung tumors were treated with SBRT at our institution between 1999 and 2009. With a median follow-u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Tetsuya, Katoh, Norio, Onimaru, Rikiya, Shirato, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399335/ https://www.ncbi.nlm.nih.gov/pubmed/22848816 http://dx.doi.org/10.1155/2012/369820

Ejemplares similares

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
por: Inoue, Tetsuya, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
por: Katoh, Norio, et al.
Publicado: (2017)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
por: Katoh, Norio, et al.
Publicado: (2018)

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects
por: Niibe, Yuzuru, et al.
Publicado: (2016)

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016)

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
por: Tabata, Ken-ichi, et al.
Publicado: (2012)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma
por: Brown, Lindsay C., et al.
Publicado: (2014)

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors
por: Cha, Yu Jin, et al.
Publicado: (2017)

Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system
por: Shimizu, Shinichi, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer
por: Kubicek, Gregory J., et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Metachronous Multisite Oligo-Recurrence: A Long-Surviving Case with Sequential Oligo-Recurrence in Four Different Organs Treated Using Locally Radical Radiotherapy and a Review of the Literature
por: Onishi, Hiroshi, et al.
Publicado: (2012)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702)
por: Nishio, Teiji, et al.
Publicado: (2014)

Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system
por: Nishioka, Kentaro, et al.
Publicado: (2018)

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702)
por: Onimaru, Rikiya, et al.
Publicado: (2018)

Prognostic Factors for Survival in Patients with High-Grade Meningioma and Recurrence-Risk Stratification for Application of Radiotherapy
por: Yamaguchi, Shigeru, et al.
Publicado: (2014)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020)

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
por: Li, Wen-Cai, et al.
Publicado: (2021)

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy
por: Toramatsu, Chie, et al.
Publicado: (2013)

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
por: Chen, Yi-Xing, et al.
Publicado: (2023)

Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer
por: Homma, A, et al.
Publicado: (2013)

Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence
por: Nakamura, Masaki, et al.
Publicado: (2018)

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
por: Triggiani, Luca, et al.
Publicado: (2017)

Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT
por: Nishioka, Kentaro, et al.
Publicado: (2013)

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
por: Nishioka, Kentaro, et al.
Publicado: (2017)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Stereotactic body radiotherapy for superior vena cava syndrome
por: Zhu, Xu, et al.
Publicado: (2022)

Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography
por: Mori, Takashi, et al.
Publicado: (2015)

Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results
por: Goyal, K., et al.
Publicado: (2010)

Salvage radiotherapy for second oligo-recurrence in patients with breast cancer
por: Miyata, Mari, et al.
Publicado: (2018)

The impact of emphysema on dosimetric parameters for stereotactic body radiotherapy of the lung
por: Ochiai, Satoru, et al.
Publicado: (2016)

Stereotactic body radiotherapy in lung cancer: an update
por: Abreu, Carlos Eduardo Cintra Vita, et al.
Publicado: (2015)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7dlbaj8cl3ikrf37fv430qv5ur